MET
About
Location: 7q31.2
Mappings
Biomarkers
MET is involved in the following curated biomarkers.
| Name | Biomarker type | Propositions | Statements |
|---|---|---|---|
| MET Exon 14 (Splice Site) | Somatic variant | 2 | 4 |
| MET Exon 14 (Deletion) | Somatic variant | 2 | 4 |
Therapeutic response
Precision oncology relationships for therapeutic response involving this gene.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (2) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Capmatinib | |
| EMA (1) FDA (2) | MET Exon 14 (Deletion) | Non-Small Cell Lung Cancer | Capmatinib | |
| EMA (1) FDA (2) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Tepotinib | |
| EMA (1) FDA (2) | MET Exon 14 (Deletion) | Non-Small Cell Lung Cancer | Tepotinib |